Stock Under Review: Tenet Healthcare Corporation (NYSE: THC)

[ad_1]

Tenet Healthcare Corporation is part of the healthcare sector and trades as part of the health care providers industry. The company CEO is Ronald A. Rittenmeyer. Tenet Healthcare Corp is a healthcare service provider in the US. The company operates acute-care hospitals that includes ambulatory surgery centers, diagnostic imaging centers, and urgent care centers across United States.

Previous Intraday Trading Performance:

The THC stock showed a previous change of -3.36% with an open at 21.52 and a close of 21.88. It reached an intraday high of 21.52 and a low of 21.30.

Business Wire:  Tenet to Participate in the UBS Global Healthcare Conference

Liquidity:

The stock has a market cap of $2.2b with 103.1m shares outstanding, of which the float is 98.8m shares. Trading volume reached 79,631 shares compared to its average volume of 1,950,305 shares. Based on the current average volume and close price, the trading liquidity is good.

Historical Trading Performance:

Over the last five trading days, Tenet Healthcare Corporation shares returned -4.33% and in the past 30 trading days it returned -24.13%. Over three months, it changed -23.44%. In one year it has changed -38.09% and within that year its 52-week high was 39.74 and its 52-week low was 16.61. THC stock is 31.77% above its 52 Week Low.

Our calculations show a 200 day moving average of 25.72 and a 50 day moving average of 25.35. Currently THC stock is trading -14.92% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

Business Wire:  Tenet to Participate in the UBS Global Healthcare Conference

Earnings:

The last annual fiscal EPS for the company was reported at 1.07 that ended on 31st of December 2018, which according to the previous close, that is a PE of 19.76. Based on 10 analyst estimates, the consensus EPS for the next quarter is 0.31. The TTM EPS is 1.86, which comes to a TTM PE of 11.37.

Below was the last reported quarterly diluted earnings per share:

1st Qtr of 2019 -0.18
4th Qtr of 2018 -0.05
3rd Qtr of 2018 -0.09
2nd Qtr of 2018 0.25
1st Qtr of 2018 0.96

Base on our calculations, the intrinsic value per share is 94.99, which means it is possibly undervalued and has a margin of safety of 76.97%.

Indicators to Watch:

Short-interest was 9,248,015, which was 8.97% of shares outstanding. The short-interest ratio or days-to-cover ratio was 9.66. This stock has a moderate level of short interest, but may still be a buying opportunity depending on other indicators.

The current calculated beta is 1.59.

PR Newswire:  TDS and U.S. Cellular announce financial leadership appointments

Fundamental Indicators:

Based on last reported financials, the company’s return on assets is -0.03%, profit margin is 1.88%, price-to-sales is 0.12 and price-to-book is 79.54.

Company Scores:

All scores are out of six:
 2  :Valuation Score
 0  :Past Performance Score
 4  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 2  :Overall Score

[ad_2]

Latest posts